Trump Eyeing ‘Disruptive’ Changes to Drug Pricing, Health Secretary Says
The Trump administration is looking to make “disruptive” changes to U.S. drug pricing to bring down costs for patients, Health and Human Services Secretary Alex Azar said.
We interviewed HHS
on drug pricing. He stressed that pharma companies set prices and PBMS aren't necessarily the bad guys “I am not blaming pharmacy-benefit managers for the position we are in around drug pricing or the dynamic of rebates”
Jared S. Hopkins
Trump's HHS secretary, Alex Azar, came to the Bloomberg office today to talk drug pricing. He told us pharmacy benefit managers aren't to blame. They're great negotiators!
More from our interview w/ HHS Secretary
: Promises "disruptive" changes on drug pricing. Says there will be some "fairly large, disruptive changing of the rules of the road.”
Don't blame the drug plans for high pharmaceutical prices. Everyone has to take some blame. The latest from HHS Secretary Alex Azar on a visit to
Trump eyeing "disruptive" changes to drug pricing, HHS secretary says